Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 41 citing articles:

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
Tien-Wei Yu, Hsien‐Yuan Lane, Chieh‐Hsin Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8208-8208
Open Access | Times Cited: 127
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 18
Role of reactive oxygen species in the progression of Alzheimer’s disease
Shvetank Bhatt, Lakshman Puli, Chandragouda R. Patil
Drug Discovery Today (2020) Vol. 26, Iss. 3, pp. 794-803
Closed Access | Times Cited: 128
Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer’s and Parkinson’s disease therapeutics
Therese S. Salameh, Elizabeth M. Rhea, Konrad Talbot, et al.
Biochemical Pharmacology (2020) Vol. 180, pp. 114187-114187
Open Access | Times Cited: 104
Memantine: Updating a rare success story in pro-cognitive therapeutics
Parisa Karimi Tari, Chris G. Parsons, Graham L. Collingridge, et al.
Neuropharmacology (2023) Vol. 244, pp. 109737-109737
Open Access | Times Cited: 27
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 916-916
Open Access | Times Cited: 22
Dance for People with Alzheimer’s Disease: A Systematic Review
Alicia Ruiz‐Muelle, María Mar López‐Rodriguez
Current Alzheimer Research (2019) Vol. 16, Iss. 10, pp. 919-933
Closed Access | Times Cited: 56
Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews
Reza Majidazar, Erfan Rezazadeh-Gavgani, Saeed Sadigh‐Eteghad, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 10, pp. 1567-1587
Closed Access | Times Cited: 36
Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
Dikshaa Padhi, Thimmaiah Govindaraju
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7088-7105
Closed Access | Times Cited: 33
Drug Discovery and Development Targeting Dementia
Agnieszka Zagórska, Anna Czopek, Monika Fryc, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 151-151
Open Access | Times Cited: 20
Panax notoginseng saponins prevent dementia and oxidative stress in brains of SAMP8 mice by enhancing mitophagy
Yingying Yang, Wenya Chen, Zhenmei Lin, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Insulin‐like growth factor‐2 is a promising candidate for the treatment and prevention of Alzheimer's disease
Greg S. Fitzgerald, T. G. Chuchta, Ewan C. McNay
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 6, pp. 1449-1469
Open Access | Times Cited: 14
New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease
Yuan Cao, Linwei Zhao, Zixin Chen, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Dementia Medications and Their Association with Pain Medication Use in Medicare Beneficiaries with Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Chronic Pain
Sadaf Arefi Milani, Jordan Westra, Yong Fang Kuo, et al.
Drugs & Aging (2025)
Open Access
Exploring Alzheimer's Disease Treatment: Established Therapies and Novel Strategies for Future Care
Urvashi Soni, Kuldeep Singh, Divya Jain, et al.
European Journal of Pharmacology (2025), pp. 177520-177520
Closed Access
Stratifying risk for dementia onset using large‐scale electronic health record data: A retrospective cohort study
Thomas H. McCoy, Larry Han, Amelia M. Pellegrini, et al.
Alzheimer s & Dementia (2019) Vol. 16, Iss. 3, pp. 531-540
Open Access | Times Cited: 42
Current trends and updates in the treatment of Alzheimer's disease
Nisha I. Parikh, Palak K. Parikh, Hetansh J. Rao, et al.
Elsevier eBooks (2024), pp. 373-390
Closed Access | Times Cited: 3
The impacts of health insurance and resource on the burden of Alzheimer's disease and related dementias in the world population
Jin‐Tao Wang, Gang Xu, Ru‐Jing Ren, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 3, pp. 967-979
Closed Access | Times Cited: 14
Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
Pallavi Duggal, Sidharth Mehan
Journal of Alzheimer s Disease Reports (2019) Vol. 3, Iss. 1, pp. 179-218
Open Access | Times Cited: 24
Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation
Izabella Góral, Tomasz Wichur, Emilia Sługocka, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 17, pp. 3181-3201
Open Access | Times Cited: 2
Memantine and its benefits for cancer, cardiovascular and neurological disorders
Vahid Shafiei‐Irannejad, Samin Abbaszadeh, Paul M.L. Janssen, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174455-174455
Closed Access | Times Cited: 17
Combined drug triads for synergic neuroprotection in retinal degeneration
Victoria Maneu, Pedro Lax, Antonio M. G. de Diego, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112911-112911
Open Access | Times Cited: 10
CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
Nathan Herrmann, Zahinoor Ismail, Rhonda Collins, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer’s disease: a cumulative meta-analysis and trial sequential analysis
Lídia Blanco-Silvente, Xavier Castells, Josep Garre‐Olmo, et al.
European Journal of Clinical Pharmacology (2019) Vol. 75, Iss. 12, pp. 1659-1667
Closed Access | Times Cited: 12
Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials
Inmaculada Xu Lou, Jiayue Chen, Kamran Ali, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top